IRIS publication 235379243
Steroid allergy in patients with inflammatory bowel disease
RIS format for Endnote and similar
TY - JOUR - Malik, M.,Tobin, A. M.,Shanahan, F.,O'Morain, C.,Kirby, B.,Bourke, J. - 2007 - November - British Journal of Dermatology - Steroid allergy in patients with inflammatory bowel disease - Validated - () - 157 - 5 - 967 - 969 - Background Contact allergy to a steroid enema leading to worsening of inflammatory bowel disease (IBD) has recently been reported. This study was designed to look for evidence of steroid allergy in patients with IBD. Objectives To look for the presence of steroid allergy in general, and steroid enema allergy in particular, in a cohort of IBD patients prepared to attend for patch testing. Methods Patients with IBD in two gastroenterology units at Dublin and Cork were asked to take part in the study. Those who agreed to take part were tested to the British Contact Dermatitis Society standard and steroid batteries. Patients with positive tests to steroids were subsequently asked to attend for intradermal testing with prednisolone, and patch testing to the two commercially available steroid enemas in Ireland and an extended battery of steroids. Reactions were read at days 2 and 4. Results In total, 44 patients from the two units were patch tested. Four patients had positive patch tests to one or more steroids in these batteries: budesonide (n = 2), triamcinolone acetonide (n = 1), tixocortol pivalate (n = 1) and prednisolone (n = 1). Of these, three underwent further testing. All three had positive reactions to intradermal prednisolone and one had a positive test to steroid enema. Conclusions Four (9%) of our patients were found to have steroid allergy. This has important implications for the local and systemic treatment of their IBD.Background Contact allergy to a steroid enema leading to worsening of inflammatory bowel disease (IBD) has recently been reported. This study was designed to look for evidence of steroid allergy in patients with IBD. Objectives To look for the presence of steroid allergy in general, and steroid enema allergy in particular, in a cohort of IBD patients prepared to attend for patch testing. Methods Patients with IBD in two gastroenterology units at Dublin and Cork were asked to take part in the study. Those who agreed to take part were tested to the British Contact Dermatitis Society standard and steroid batteries. Patients with positive tests to steroids were subsequently asked to attend for intradermal testing with prednisolone, and patch testing to the two commercially available steroid enemas in Ireland and an extended battery of steroids. Reactions were read at days 2 and 4. Results In total, 44 patients from the two units were patch tested. Four patients had positive patch tests to one or more steroids in these batteries: budesonide (n = 2), triamcinolone acetonide (n = 1), tixocortol pivalate (n = 1) and prednisolone (n = 1). Of these, three underwent further testing. All three had positive reactions to intradermal prednisolone and one had a positive test to steroid enema. Conclusions Four (9%) of our patients were found to have steroid allergy. This has important implications for the local and systemic treatment of their IBD. - 0007-09630007-0963 - ://WOS:000250144800018://WOS:000250144800018 DA - 2007/11 ER -
BIBTeX format for JabRef and similar
@article{V235379243, = {Malik, M. and Tobin, A. M. and Shanahan, F. and O'Morain, C. and Kirby, B. and Bourke, J. }, = {2007}, = {November}, = {British Journal of Dermatology}, = {Steroid allergy in patients with inflammatory bowel disease}, = {Validated}, = {()}, = {157}, = {5}, pages = {967--969}, = {{Background Contact allergy to a steroid enema leading to worsening of inflammatory bowel disease (IBD) has recently been reported. This study was designed to look for evidence of steroid allergy in patients with IBD. Objectives To look for the presence of steroid allergy in general, and steroid enema allergy in particular, in a cohort of IBD patients prepared to attend for patch testing. Methods Patients with IBD in two gastroenterology units at Dublin and Cork were asked to take part in the study. Those who agreed to take part were tested to the British Contact Dermatitis Society standard and steroid batteries. Patients with positive tests to steroids were subsequently asked to attend for intradermal testing with prednisolone, and patch testing to the two commercially available steroid enemas in Ireland and an extended battery of steroids. Reactions were read at days 2 and 4. Results In total, 44 patients from the two units were patch tested. Four patients had positive patch tests to one or more steroids in these batteries: budesonide (n = 2), triamcinolone acetonide (n = 1), tixocortol pivalate (n = 1) and prednisolone (n = 1). Of these, three underwent further testing. All three had positive reactions to intradermal prednisolone and one had a positive test to steroid enema. Conclusions Four (9%) of our patients were found to have steroid allergy. This has important implications for the local and systemic treatment of their IBD.Background Contact allergy to a steroid enema leading to worsening of inflammatory bowel disease (IBD) has recently been reported. This study was designed to look for evidence of steroid allergy in patients with IBD. Objectives To look for the presence of steroid allergy in general, and steroid enema allergy in particular, in a cohort of IBD patients prepared to attend for patch testing. Methods Patients with IBD in two gastroenterology units at Dublin and Cork were asked to take part in the study. Those who agreed to take part were tested to the British Contact Dermatitis Society standard and steroid batteries. Patients with positive tests to steroids were subsequently asked to attend for intradermal testing with prednisolone, and patch testing to the two commercially available steroid enemas in Ireland and an extended battery of steroids. Reactions were read at days 2 and 4. Results In total, 44 patients from the two units were patch tested. Four patients had positive patch tests to one or more steroids in these batteries: budesonide (n = 2), triamcinolone acetonide (n = 1), tixocortol pivalate (n = 1) and prednisolone (n = 1). Of these, three underwent further testing. All three had positive reactions to intradermal prednisolone and one had a positive test to steroid enema. Conclusions Four (9%) of our patients were found to have steroid allergy. This has important implications for the local and systemic treatment of their IBD.}}, issn = {0007-09630007-0963}, = {://WOS:000250144800018://WOS:000250144800018}, source = {IRIS} }
Data as stored in IRIS
AUTHORS | Malik, M.,Tobin, A. M.,Shanahan, F.,O'Morain, C.,Kirby, B.,Bourke, J. | ||
YEAR | 2007 | ||
MONTH | November | ||
JOURNAL_CODE | British Journal of Dermatology | ||
TITLE | Steroid allergy in patients with inflammatory bowel disease | ||
STATUS | Validated | ||
TIMES_CITED | () | ||
SEARCH_KEYWORD | |||
VOLUME | 157 | ||
ISSUE | 5 | ||
START_PAGE | 967 | ||
END_PAGE | 969 | ||
ABSTRACT | Background Contact allergy to a steroid enema leading to worsening of inflammatory bowel disease (IBD) has recently been reported. This study was designed to look for evidence of steroid allergy in patients with IBD. Objectives To look for the presence of steroid allergy in general, and steroid enema allergy in particular, in a cohort of IBD patients prepared to attend for patch testing. Methods Patients with IBD in two gastroenterology units at Dublin and Cork were asked to take part in the study. Those who agreed to take part were tested to the British Contact Dermatitis Society standard and steroid batteries. Patients with positive tests to steroids were subsequently asked to attend for intradermal testing with prednisolone, and patch testing to the two commercially available steroid enemas in Ireland and an extended battery of steroids. Reactions were read at days 2 and 4. Results In total, 44 patients from the two units were patch tested. Four patients had positive patch tests to one or more steroids in these batteries: budesonide (n = 2), triamcinolone acetonide (n = 1), tixocortol pivalate (n = 1) and prednisolone (n = 1). Of these, three underwent further testing. All three had positive reactions to intradermal prednisolone and one had a positive test to steroid enema. Conclusions Four (9%) of our patients were found to have steroid allergy. This has important implications for the local and systemic treatment of their IBD.Background Contact allergy to a steroid enema leading to worsening of inflammatory bowel disease (IBD) has recently been reported. This study was designed to look for evidence of steroid allergy in patients with IBD. Objectives To look for the presence of steroid allergy in general, and steroid enema allergy in particular, in a cohort of IBD patients prepared to attend for patch testing. Methods Patients with IBD in two gastroenterology units at Dublin and Cork were asked to take part in the study. Those who agreed to take part were tested to the British Contact Dermatitis Society standard and steroid batteries. Patients with positive tests to steroids were subsequently asked to attend for intradermal testing with prednisolone, and patch testing to the two commercially available steroid enemas in Ireland and an extended battery of steroids. Reactions were read at days 2 and 4. Results In total, 44 patients from the two units were patch tested. Four patients had positive patch tests to one or more steroids in these batteries: budesonide (n = 2), triamcinolone acetonide (n = 1), tixocortol pivalate (n = 1) and prednisolone (n = 1). Of these, three underwent further testing. All three had positive reactions to intradermal prednisolone and one had a positive test to steroid enema. Conclusions Four (9%) of our patients were found to have steroid allergy. This has important implications for the local and systemic treatment of their IBD. | ||
PUBLISHER_LOCATION | |||
ISBN_ISSN | 0007-09630007-0963 | ||
EDITION | |||
URL | ://WOS:000250144800018://WOS:000250144800018 | ||
DOI_LINK | |||
FUNDING_BODY | |||
GRANT_DETAILS |